Hyperhomocysteinaemia: a critical review of old and new aspects

Wolfgang Herrmann1, Markus Herrmann, Rima Obeid

  • 1Clinical Chemistry and Laboratory Medicine/Central Laboratory, Saarland University Medical School, 66421 Homburg, Germany. kchwher@uniklinikum-saarland.de

Current Drug Metabolism
|February 3, 2007
PubMed

Insights

High homocysteine (HHCY) is linked to cardiovascular disease, stroke, and cognitive decline. B-vitamin supplementation effectively reduces stroke risk by approximately 20% and may lower fracture and pregnancy complication risks.

Area of Science:

  • Biochemistry
  • Cardiovascular Medicine
  • Neurology

Background:

  • Hyperhomocysteinemia (HHCY), often due to B-vitamin deficiency, is a significant risk factor for cardiovascular diseases (CVD), neurodegenerative disorders, osteoporotic fractures, and pregnancy complications.
  • While some vitamin intervention trials have yielded inconclusive results for CVD risk reduction, confounding factors and limited statistical power have been noted.

Purpose of the Study:

  • To evaluate the effectiveness of B-vitamin supplementation in mitigating risks associated with Hyperhomocysteinemia.
  • To clarify the role of B-vitamins in preventing stroke, fractures, cognitive decline, and pregnancy complications.

Main Methods:

  • Re-analysis of existing studies, such as the VISP trial, excluding confounding variables.
  • Examination of data from large-scale trials and population-based observations, including the HOPE 2 trial and effects of grain fortification.

Main Results:

  • Re-analysis of the VISP study indicated a 21% reduction in stroke risk after adjustments.
  • The HOPE 2 trial and folate fortification in grain products demonstrated significant reductions in stroke mortality (8-16%).
  • Evidence suggests B-vitamin supplementation can lower stroke risk by approximately 20%, reduce osteoporotic fracture risk, and decrease pregnancy complications.

Conclusions:

  • B-vitamin supplementation, particularly with folate, is effective in reducing stroke risk and mortality.
  • Addressing Hyperhomocysteinemia through vitamin supplementation offers potential benefits for reducing osteoporotic fractures, mitigating cognitive decline, and preventing pregnancy complications.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...